What is TTRX's shares (basic)?

TTRX (TTRX) reported shares (basic) of 29.5M in Q1 2026.

How has TTRX's shares (basic) changed year-over-year?

TTRX's shares (basic) increased by 9.3% year-over-year, from 27M to 29.5M.

What does shares (basic) mean?

The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.

TTRX TTRX Shares (Basic)

Shares (Basic) at other companies

Regeneron PharmaceuticalsREGN

104M-2.5%

Bausch Health CompaniesBHC

372.8M+0.9%

Journey Medical CorporationDERM

27.3M+20.8%

PTH

Pelthos Therapeutics Inc.PTHS

3.3M+440%

Celldex TherapeuticsCLDX

66.6M+0.3%

Arcutis Biotherapeutics, Inc.ARQT

129.4M+2.6%

Other financials

Income statement

See full

Operating income-$1.2M-224%

Net income-$971.0K-196%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$11.2M+613%

Total debt$6.0M—

Total equity$6.1M+647%

Total assets$18.6M—

Cash flow

See full

Operating cash flow-$1.6M-448%

Valuation

See full

Market cap$217.45M-17.7%

Enterprise value$212.24M—

Returns & leverage

See full

Return on equity-118.8%—

Debt / equity1×—

Current ratio2.2×—

Where this comes from

Reported directly by TTRX in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TTRX's shares (basic)?: TTRX (TTRX) reported shares (basic) of 29.5M in Q1 2026.
How has TTRX's shares (basic) changed year-over-year?: TTRX's shares (basic) increased by 9.3% year-over-year, from 27M to 29.5M.
What does shares (basic) mean?: The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.